Literature DB >> 11090190

Identification of a domain in human immunodeficiency virus type 1 rev that is required for functional activity and modulates association with subnuclear compartments containing splicing factor SC35.

D M D'Agostino1, T Ferro, L Zotti, F Meggio, L A Pinna, L Chieco-Bianchi, V Ciminale.   

Abstract

The activity of human immunodeficiency virus Rev as a regulator of viral mRNA expression is tightly linked to its ability to shuttle between the nucleus and cytoplasm; these properties are conferred by a leucine-rich nuclear export signal (NES) and by an arginine-rich nuclear localization signal/RNA binding domain (NLS/RBD) required for binding to the Rev-responsive element (RRE) located on viral unspliced and singly spliced mRNAs. Structure predictions and biophysical measurements indicate that Rev consists of an unstructured region followed by a helix-loop-helix motif containing the NLS/RBD and sequences directing multimerization and by a carboxy-terminal tail containing the NES. We present evidence that the loop portion of the helix-loop-helix region is an essential functional determinant that is required for binding to the RRE and for correct intracellular routing. Data obtained using a protein kinase CK2 phosphorylation assay indicated that the loop region is essential for juxtaposition of helices 1 and 2 and phosphorylation by protein kinase CK2. Deletion of the loop resulted in partial accumulation of Rev in SC35-positive nuclear bodies that resembled nuclear bodies that form in response to inhibition of transcription. Accumulation of the DeltaLoop mutant in nuclear bodies depended on the presence of an intact NES, suggesting that both the loop and the NES play a role in controlling intranuclear compartmentalization of Rev and its association with splicing factors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11090190      PMCID: PMC112473          DOI: 10.1128/jvi.74.24.11899-11910.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  82 in total

1.  HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency.

Authors:  M H Malim; B R Cullen
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

2.  Characterization of HIV-1 REV protein: binding stoichiometry and minimal RNA substrate.

Authors:  K S Cook; G J Fisk; J Hauber; N Usman; T J Daly; J R Rusche
Journal:  Nucleic Acids Res       Date:  1991-04-11       Impact factor: 16.971

3.  Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif.

Authors:  M L Zapp; T J Hope; T G Parslow; M R Green
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

4.  Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein.

Authors:  L S Tiley; M H Malim; H K Tewary; P G Stockley; B R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

5.  Specific regulation of mRNA splicing in vitro by a peptide from HIV-1 Rev.

Authors:  J Kjems; A D Frankel; P A Sharp
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

6.  The amino terminal domain of HIV-1 Rev is required for discrimination of the RRE from nonspecific RNA.

Authors:  T J Daly; R C Doten; J R Rusche; M Auer
Journal:  J Mol Biol       Date:  1995-10-20       Impact factor: 5.469

7.  Binding of trans-dominant mutant Rev protein of human immunodeficiency virus type 1 to the cis-acting Rev-responsive element does not affect the fate of viral mRNA.

Authors:  D M Benko; R Robinson; L Solomin; M Mellini; B K Felber; G N Pavlakis
Journal:  New Biol       Date:  1990-12

8.  Herpes simplex virus trans-regulatory protein ICP27 stabilizes and binds to 3' ends of labile mRNA.

Authors:  C R Brown; M S Nakamura; J D Mosca; G S Hayward; S E Straus; L P Perera
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Associations between distinct pre-mRNA splicing components and the cell nucleus.

Authors:  D L Spector; X D Fu; T Maniatis
Journal:  EMBO J       Date:  1991-11       Impact factor: 11.598

10.  The roles of nucleolar structure and function in the subcellular location of the HIV-1 Rev protein.

Authors:  M Dundr; G H Leno; M L Hammarskjöld; D Rekosh; C Helga-Maria; M O Olson
Journal:  J Cell Sci       Date:  1995-08       Impact factor: 5.285

View more
  5 in total

1.  HIV-1 Rev transactivator: a beta-subunit directed substrate and effector of protein kinase CK2.

Authors:  F Meggio; O Marin; M Boschetti; S Sarno; L A Pinna
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

2.  Phosphorylation of RIG-I by casein kinase II inhibits its antiviral response.

Authors:  Zhiguo Sun; Hongwei Ren; Yan Liu; Jessica L Teeling; Jun Gu
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

3.  Recruitment of the Crm1 nuclear export factor is sufficient to induce cytoplasmic expression of incompletely spliced human immunodeficiency virus mRNAs.

Authors:  Rui Yi; Hal P Bogerd; Bryan R Cullen
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  Intermolecular masking of the HIV-1 Rev NLS by the cellular protein HIC: novel insights into the regulation of Rev nuclear import.

Authors:  Lili Gu; Takahiro Tsuji; Mohamed Ali Jarboui; Geok P Yeo; Noreen Sheehy; William W Hall; Virginie W Gautier
Journal:  Retrovirology       Date:  2011-03-14       Impact factor: 4.602

5.  Nuclear Import of the HIV-1 Core Precedes Reverse Transcription and Uncoating.

Authors:  Anastasia Selyutina; Mirjana Persaud; Kyeongeun Lee; Vineet KewalRamani; Felipe Diaz-Griffero
Journal:  Cell Rep       Date:  2020-09-29       Impact factor: 9.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.